Management of Adverse Events and Other Practical Considerations in Patients Receiving Capecitabine (Xeloda)

    Hilde Marsé, Éric Van Cutsem, Axel Grothey, Silvia Valverde
    Studysummary In patients undergoing treatment with capecitabine for colon cancer and metastatic breast cancer, this study observed that hand-foot syndrome occurred more frequently than with intravenous 5-FU, but other side effects were less common.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on ejoncologynursing.com →
    Discuss this study in the Community →